All News
🟢 Karman Holdings is trading 5% up on October 29, 2026
Karman Holdings is trading at $39.99, up 5.29%, with no clear, newly reported company-specific catalyst identified for the intraday rise. - Recent coverage...
🟢 Littelfuse is trading 4.5% up today after Q4 EPS guidance topped expectations
Littelfuse is trading at $404.73, up 4.54%, as its earnings beat and bullish Q4 outlook drove the October 29 advance. - October 28 results showed record...
🟢 Lianhe Sowell is trading 9.8% up; no verified company-specific explanation
Lianhe Sowell is trading 9.8% higher at $4.75 on October 29, 2026, with no verified company-specific announcement explaining the move. - The broader U.S....
🟢 Metalurgica Gerdau is trading 4.41% up after upbeat Q3 EBITDA and cash flow
Metalurgica Gerdau is trading at BRL 11.12, up +4.41%, likely supported by upbeat Q3 commentary. - Gerdau reported BRL 3.8 billion in EBITDA, a 20.2% margin...
🟢 Howmet Aerospace is trading 5% up today after 29% revenue growth in Q3
Howmet Aerospace is trading at $204.78 (+4.91%) after October 29 results showed 29% year-over-year revenue growth and adjusted EPS of $1.46, beating analyst...
🔴 Huadi International Group is trading 6% down with no clear company-specific catalyst reported
Huadi International Group is trading at $0.46, down -5.71%, with no clearly reported company-specific catalyst identified. - Searches found no company...
🟢 GE Aerospace is trading 3.27% up today amid defense-stock strength, with no direct catalyst confirmed
GE Aerospace is trading 3.27% up at $310.98 on October 29, 2026, with defense-sector strength offering context but no confirmed company-specific catalyst. - No...
🟢 Gogo is trading 5% up; no clear catalyst identified
Gogo is trading at $2.54, up 5.17%, with no specific announcement found to explain the October 29 move. - TransMedics selected Gogo Galileo for 22 aircraft,...
🔴 Google is trading 12.18% down today after Q3 profit and revenue missed expectations
Google is trading at ARS 8,180, down 12.18%, after Alphabet’s Q3 results missed profit and revenue expectations. - Reported free cash flow was negative $9.07...
🟢 GE Vernova is trading 3.43% up today after Q3 results beat expectations
GE Vernova is trading at $908.12, up 3.43%, after third-quarter results beat expectations. - October 29 results included $29.3 billion in orders and a $197...
🟢 Generac Holdings is trading 4.27% up today after adjusted EPS beat estimates
Generac Holdings is trading 4.27% up at $209.94 after its October 28 third-quarter results showed adjusted EPS of $2.54, above estimates. - Data-center...
🟢 GH Research is trading 5% up
GH Research is trading at $21.80 (+5.26%), with the reason for the gain unclear. - No clear company-specific announcement explaining the October 29 move was...
🟢 Generate Biomedicines is trading 6.8% up
Generate Biomedicines is trading at $16.43, up 6.79% during the October 29 session, with no clear company-specific catalyst identified. - Its latest listed...
🟢 Gelteq is trading 6.17% up
Gelteq is trading at $0.52, up +6.17%, with no confirmed catalyst for the October 29 move. - The news search found no Gelteq-specific announcement; its...
🔴 DPM Metals is trading 4.2% down amid precious-metals weakness
DPM Metals is trading at CA$49.80, down 4.19%, with precious-metals weakness a plausible sector headwind. - Gold was reported down 0.7% as investors assessed...
🟢 Damora Therapeutics is trading 6.4% up today amid healthcare-sector gains
Damora Therapeutics is trading 6.43% higher at $23.00 on October 29, 2026, with healthcare-sector strength the most relevant available context. - Healthcare...
🔴 CoreWeave is trading 3.8% down today as cloud and AI stocks weakened
CoreWeave is trading at $2.40, down 3.80%, amid weakness in cloud and AI infrastructure stocks. - On October 29, Alphabet and ServiceNow earnings intensified...
🔴 Cognizant is trading 4.36% down today after narrowing its 2026 revenue growth outlook
Cognizant is trading 4.36% down at $63.47 after its October 29 earnings report narrowed its 2026 constant-currency revenue growth outlook to 4.0%–4.4%. - The...
🔴 CervoMed is trading 6.3% down today after Phase 2b trial missed primary outcome
CervoMed is trading 6.3% lower at $2.07 after its Phase 2b RewinD-LB trial failed to confirm the primary outcome in the full study population. - Results from...
🟢 Conexeu Sciences is trading 5.73% up, with no clear catalyst identified
Conexeu Sciences is trading at $3.04, up 5.73%, with no clear October 29 company-specific catalyst identified. - A recent SEC exhibit describes an inducement...